Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids
Authors:
- 1 August 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (16) , 3643-3646
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Isatin hybrids and their anti-tuberculosis activityChinese Chemical Letters, 2017
- 1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluationEuropean Journal of Medicinal Chemistry, 2014
- Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterialsEuropean Journal of Medicinal Chemistry, 2012
- New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agentsEuropean Journal of Medicinal Chemistry, 2011
- Synthesis and in vitro antimycobacterial activity of 8-OCH3 ciprofloxacin methylene and ethylene isatin derivativesEuropean Journal of Medicinal Chemistry, 2011
- Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agentsProceedings of the National Academy of Sciences, 2010
- Gatifloxacin derivatives: Synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyraseBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivativesBioorganic & Medicinal Chemistry, 2005
- Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivativesBioorganic & Medicinal Chemistry, 2005
- A Chemoenzymatic Approach to Glycopeptide AntibioticsJournal of the American Chemical Society, 2004